Appendix 4E and 2025 Annual Report
- Date and time
- Announcement type
- Financial Results
Show detailsHide details
- Category
- Reports
- Report codes
- 03001, 03002, 03003, 03011, 03012, 03013, 03020
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences
Recent DXB announcements
- Dimerix Receives US$10M Upfront Payment from Everest
- Dimerix Assumes Sponsorship of US IND for New Asset DMX-652
- Dimerix Presents at Bioshares Summit 2026
- Dimerix Quarterly Activities Report and Appendix 4C
- Dimerix to Present at TechKnow Invest Conference 2026
- US Patent Granted for Dimerix New Asset DMX-652